Bebo HealthXPAR:MLBBO 47 Operating Margin % is 4.13% as of Dec. 2025, which is 22% below its 10-year median of 5.32. GuruFocus rates XPAR:MLBBO with a GF Score™ of 47/100 and a GF Value™ of €0.03 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 1,124 Retail - Cyclical companies, Bebo Health ranks better than 50.98% on this metric.
Operating Margin % is calculated as Operating Income divided by its Revenue. Bebo Health's Operating Income for the
six
months ended in Dec. 2025 was €1.04 Mil. Bebo Health's Revenue for the
six
months ended in Dec. 2025 was €25.25 Mil. Therefore, Bebo Health's Operating Margin % for the quarter that ended in Dec. 2025 was 4.13%.
The historical rank and industry rank for Bebo Health's Operating Margin % or its related term are showing as below:
XPAR:MLBBO'
s Operating Margin % Range Over the Past 10 Years
Min: -0.26 Med: 5.32 Max: 10
Current: 4.14
XPAR:MLBBO's Operating Margin % is ranked better than 50.98% of 1124
companies
in the Retail - Cyclical industry
Industry Median: 3.925
vs XPAR:MLBBO: 4.14
Bebo Health's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.
Bebo Health's Operating Income for the
six
months ended in Dec. 2025 was €1.04 Mil.
Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2025 was €1.04 Mil.
Bebo Health (XPAR:MLBBO) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Bebo Health Operating Margin % Related Terms
Bebo Health Operating Margin % Historical Data
* Premium members only.
The historical data trend for Bebo Health's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XPAR:MLBBO vs CASY, WSM, DKS: Operating Margin % Comparison
For the Specialty Retail subindustry, Bebo Health's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bebo Health Operating Margin % vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, Bebo Health's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Bebo Health's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Bebo Health's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bebo Health (XPAR:MLBBO) has a Operating Margin % of 4.13% as of Dec. 2025. Operating margin is the ratio of total operating income to net sales. View historical data on Bebo Health and its competitors. This is 22% below median its historical median of 5.32. According to the industry distribution chart, Bebo Health ranks #551 out of 1124 companies in the Retail - Cyclical industry, placing it in the top 49%.
Is Bebo Health's Operating Margin % too high?
Bebo Health's current Operating Margin % of 4.13% is 22% below median its 10-year median of 5.32. The Retail - Cyclical industry median Operating Margin % is 3.93. Bebo Health's value of 4.13% is 5.2% above this industry median. Based on the distribution chart, Bebo Health ranks #551 out of 1124 companies in the Retail - Cyclical industry, which is above the industry midpoint. Overall, Bebo Health has a GF Score™ of 47/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bebo Health's Operating Margin % compare to CASY and WSM?
According to the Retail - Cyclical industry distribution chart, Bebo Health ranks #551 out of 1124 companies for Operating Margin %. This puts Bebo Health in the upper half of its industry. The industry median Operating Margin % is 3.93. Bebo Health's value of 4.13% is 5.2% above this benchmark. While the company's 10-year median is 5.32 vs. the industry median of 3.93, Bebo Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Retail - Cyclical company?
The median Operating Margin % among Retail - Cyclical companies is 3.93, based on 1,124 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bebo Health's current Operating Margin % of 4.13% is 5.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Bebo Health and its competitors. For the Retail - Cyclical industry, the median Operating Margin % is 3.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bebo Health's current Operating Margin % is 4.13%, which is 22% below median its own 10-year median of 5.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bebo Health stock overvalued right now?
Based on GuruFocus' analysis, Bebo Health (XPAR:MLBBO) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.03, compared to a current price of €0.23 — trading 660% above its estimated fair value. The current Operating Margin % is 4.13%, which is 22% below median its 10-year median of 5.32 and 5.2% above the Retail - Cyclical industry median of 3.93. Bebo Health's overall GF Score™ is 47/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Bebo Health (XPAR:MLBBO), the current Operating Margin % is 4.13% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bebo Health (XPAR:MLBBO) Overvalued in 2026?
Based on GuruFocus' analysis, Bebo Health stock appears to be overvalued.
The current stock price of €0.23 is trading 660% above its estimated GF Value™ of €0.03.
GuruFocus considers Bebo Health to be Significantly Overvalued.
Key valuation signals for XPAR:MLBBO:
Operating Margin %: 4.13% (22% below median its 10-year median of 5.32)
GF Value™: €0.03 vs. price of €0.23 (660% above fair value)
Industry Position: 5.2% above the Retail - Cyclical median (#551 of 1124)
No single metric tells the full story. See the XPAR:MLBBO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:MLBBO has been successfully added to your 